Unger, J. M. et al. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials. J. Clin. Oncol. 40, 1474–1486 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zucker, I. & Prendergast, B. J. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol. Sex Differ. 11, 32 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wagner, A. D. et al. Gender medicine and oncology: report and consensus of an ESMO Workshop. Ann. Oncol. 30, 1914–1928 (2019).

Article  CAS  PubMed  Google Scholar 

Hopkins, J. J. & Sawyer, M. B. Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments. Cancer Chemother. Pharmacol. 82, 1–29 (2018).

Article  CAS  PubMed  Google Scholar 

Trinkner, P. et al. Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis. Eur. J. Cancer 184, 151–171 (2023).

Article  CAS  PubMed  Google Scholar 

Wagner, A. D. et al. Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database. J. Clin. Oncol. 38, 4029–4029 (2020).

Article  Google Scholar 

Ye, Y. et al. Sex-associated molecular differences for cancer immunotherapy. Nat. Commun. 11, 1779 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah, M., Rahman, A., Theoret, M. R. & Pazdur, R. The drug-dosing conundrum in oncology — when less is more. N. Eng. J. Med. 385, 1445–1447 (2021).

Article  Google Scholar 

Jenei, K., Meyers, D. E. & Prasad, V. The inclusion of women in global oncology drug trials over the past 20 years. JAMA Oncol. 7, 1569–1570 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Jenei, K., Raymakers, A., Meyers, D. E. & Prasad, V. Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015–2020. J. Cancer Policy 30, 100311 (2021).

Article  PubMed  Google Scholar 

Özdemir, B. C., Richters, A., Espinosa da Silva, C. & Berner, A. M. Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research. iScience 26, 106212 (2023).

Article  PubMed  PubMed Central  Google Scholar